177 related articles for article (PubMed ID: 25193040)
1. Prevalence and characteristics of lactose non-fermenting Escherichia coli in urinary isolates.
Chang J; Yu J; Lee H; Ryu H; Park K; Park YJ
J Infect Chemother; 2014 Nov; 20(11):738-40. PubMed ID: 25193040
[TBL] [Abstract][Full Text] [Related]
2. Emergence and spread of B2-ST131-O25b, B2-ST131-O16 and D-ST405 clonal groups among extended-spectrum-β-lactamase-producing Escherichia coli in Japan.
Matsumura Y; Yamamoto M; Nagao M; Hotta G; Matsushima A; Ito Y; Takakura S; Ichiyama S;
J Antimicrob Chemother; 2012 Nov; 67(11):2612-20. PubMed ID: 22843833
[TBL] [Abstract][Full Text] [Related]
3. Prevalence of ST131 Clone Producing Both ESBL CTX-M-15 and AAC(6')Ib-cr Among Ciprofloxacin-Resistant
Alsharapy SA; Yanat B; Lopez-Cerero L; Nasher SS; Díaz-De-Alba P; Pascual Á; Rodríguez-Martínez JM; Touati A
Microb Drug Resist; 2018 Dec; 24(10):1537-1542. PubMed ID: 29883247
[No Abstract] [Full Text] [Related]
4. National survey of Escherichia coli causing extraintestinal infections reveals the spread of drug-resistant clonal groups O25b:H4-B2-ST131, O15:H1-D-ST393 and CGA-D-ST69 with high virulence gene content in Spain.
Blanco J; Mora A; Mamani R; López C; Blanco M; Dahbi G; Herrera A; Blanco JE; Alonso MP; García-Garrote F; Chaves F; Orellana MÁ; Martínez-Martínez L; Calvo J; Prats G; Larrosa MN; González-López JJ; López-Cerero L; Rodríguez-Baño J; Pascual A
J Antimicrob Chemother; 2011 Sep; 66(9):2011-21. PubMed ID: 21669946
[TBL] [Abstract][Full Text] [Related]
5. Molecular epidemiology and virulence of Escherichia coli O16:H5-ST131: comparison with H30 and H30-Rx subclones of O25b:H4-ST131.
Dahbi G; Mora A; Mamani R; López C; Alonso MP; Marzoa J; Blanco M; Herrera A; Viso S; García-Garrote F; Tchesnokova V; Billig M; de la Cruz F; de Toro M; González-López JJ; Prats G; Chaves F; Martínez-Martínez L; López-Cerezo L; Denamur E; Blanco J
Int J Med Microbiol; 2014 Nov; 304(8):1247-57. PubMed ID: 25455219
[TBL] [Abstract][Full Text] [Related]
6. Dissemination of ST131 and ST393 community-onset, ciprofloxacin-resistant Escherichia coli clones causing urinary tract infections in Korea.
Lee MY; Choi HJ; Choi JY; Song M; Song Y; Kim SW; Chang HH; Jung SI; Kim YS; Ki HK; Son JS; Kwon KT; Heo ST; Yeom JS; Shin SY; Chung DR; Peck KR; Song JH; Ko KS
J Infect; 2010 Feb; 60(2):146-53. PubMed ID: 19932131
[TBL] [Abstract][Full Text] [Related]
7. First report of the new emerging global clone ST1193 among clinical isolates of extended-spectrum β-lactamase (ESBL)-producing Escherichia coli from Germany.
Valenza G; Werner M; Eisenberger D; Nickel S; Lehner-Reindl V; Höller C; Bogdan C
J Glob Antimicrob Resist; 2019 Jun; 17():305-308. PubMed ID: 30682563
[TBL] [Abstract][Full Text] [Related]
8. Fluoroquinolone-Resistant Sequence Type 131 Subgroups O25b and O16 Among Extraintestinal Escherichia coli Isolates from Community-Acquired Urinary Tract Infections.
Hefzy EM; Hassuna NA
Microb Drug Resist; 2017 Mar; 23(2):224-229. PubMed ID: 27214282
[TBL] [Abstract][Full Text] [Related]
9. Molecular epidemiology and genetic diversity of fluoroquinolone-resistant Escherichia coli isolates from patients with community-onset infections in 30 Chinese county hospitals.
Zhao L; Zhang J; Zheng B; Wei Z; Shen P; Li S; Li L; Xiao Y
J Clin Microbiol; 2015 Mar; 53(3):766-70. PubMed ID: 25520451
[TBL] [Abstract][Full Text] [Related]
10. MECHANISMS OF RESISTANCE TO CIPROFLOXACIN AND GENETIC DIVERSITY OF ESCHERICHIA COLI STRAINS ORIGINATING FROM URINE CULTURES PERFORMED FOR ROMANIAN ADULTS.
Cristea VC; Oprea M; Neacşu G; Gîlcă R; Popa MI; Usein CR
Roum Arch Microbiol Immunol; 2015; 74(3-4):73-8. PubMed ID: 27328520
[TBL] [Abstract][Full Text] [Related]
11. Molecular Characteristics of ST1193 Clone among Phylogenetic Group B2 Non-ST131 Fluoroquinolone-Resistant
Wu J; Lan F; Lu Y; He Q; Li B
Front Microbiol; 2017; 8():2294. PubMed ID: 29209300
[No Abstract] [Full Text] [Related]
12. Molecular characterization of extraintestinal Escherichia coli isolates in Japan: relationship between sequence types and mutation patterns of quinolone resistance-determining regions analyzed by pyrosequencing.
Aoike N; Saga T; Sakata R; Yoshizumi A; Kimura S; Iwata M; Yoshizawa S; Sugasawa Y; Ishii Y; Yamaguchi K; Tateda K
J Clin Microbiol; 2013 Jun; 51(6):1692-8. PubMed ID: 23515543
[TBL] [Abstract][Full Text] [Related]
13. Contribution of mutations in DNA gyrase and topoisomerase IV genes to ciprofloxacin resistance in Escherichia coli clinical isolates.
Bansal S; Tandon V
Int J Antimicrob Agents; 2011 Mar; 37(3):253-5. PubMed ID: 21236644
[TBL] [Abstract][Full Text] [Related]
14. Characterization of Inhibitor-Resistant TEM β-Lactamases and Mechanisms of Fluoroquinolone Resistance in Escherichia coli Isolates.
Ríos E; López MC; Rodríguez-Avial I; Pena I; Picazo JJ
Microb Drug Resist; 2015 Oct; 21(5):512-5. PubMed ID: 25945693
[TBL] [Abstract][Full Text] [Related]
15. [Bloodstream infections with
Zhong Y; Zhang X; Liu W; Yang F; Yan Q; Liu Q; Li Y; Li H; Zou M
Nan Fang Yi Ke Da Xue Xue Bao; 2018 Dec; 38(12):1521-1526. PubMed ID: 30613024
[TBL] [Abstract][Full Text] [Related]
16. High prevalence of plasmid-mediated quinolone resistance determinant aac(6')-Ib-cr amongst Salmonella enterica serotype Typhimurium isolates from hospitalised paediatric patients with diarrhoea in China.
Yu F; Chen Q; Yu X; Pan J; Li Q; Yang L; Chen C; Zhuo C; Li X; Zhang X; Huang J; Wang L
Int J Antimicrob Agents; 2011 Feb; 37(2):152-5. PubMed ID: 21163630
[TBL] [Abstract][Full Text] [Related]
17.
Zhong YM; Liu WE; Meng Q; Li Y
Infect Drug Resist; 2019; 12():2693-2702. PubMed ID: 31564918
[TBL] [Abstract][Full Text] [Related]
18. Molecular characteristics of extended-spectrum beta-lactamase-producing Escherichia coli from the Chicago area: high prevalence of ST131 producing CTX-M-15 in community hospitals.
Peirano G; Costello M; Pitout JD
Int J Antimicrob Agents; 2010 Jul; 36(1):19-23. PubMed ID: 20359869
[TBL] [Abstract][Full Text] [Related]
19. Bacteraemia due to non-ESBL-producing Escherichia coli O25b:H4 sequence type 131: insights into risk factors, clinical features and outcomes.
Morales-Barroso I; López-Cerero L; Molina J; Bellido M; Navarro MD; Serrano L; González-Galán V; Praena J; Pascual A; Rodríguez-Baño J
Int J Antimicrob Agents; 2017 Apr; 49(4):498-502. PubMed ID: 28257756
[TBL] [Abstract][Full Text] [Related]
20. Rapid and specific detection, molecular epidemiology, and experimental virulence of the O16 subgroup within Escherichia coli sequence type 131.
Johnson JR; Clermont O; Johnston B; Clabots C; Tchesnokova V; Sokurenko E; Junka AF; Maczynska B; Denamur E
J Clin Microbiol; 2014 May; 52(5):1358-65. PubMed ID: 24501035
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
